SciSparc and Clearmind Medicine Reflect on Successful Collaboration in 2023 Aiming to Upgrade ...

The collaboration included six different provisional patent applications filed by Clearmind with the United States Patent and Trademark Office in February 2023 to protect the novel combinations of psychedelics with

Related Keywords

United States ,Israel , ,Clearmind Medicine Inc ,Nasdaq ,Scisparc Ltd ,Trademark Office ,Company Or Scisparc ,Exchange Commission ,United States Patent ,Clearmind Medicine ,Tourette Syndrome ,Looking Statements ,Private Securities Litigation Reform Act ,Annual Report ,Region ,